{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:48:56Z","timestamp":1777556936362,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["PDM\/19\/164"],"award-info":[{"award-number":["PDM\/19\/164"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1080405"],"award-info":[{"award-number":["APP1080405"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FL150100146"],"award-info":[{"award-number":["FL150100146"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT160100055"],"award-info":[{"award-number":["FT160100055"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bcp.2020.114291","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T02:08:50Z","timestamp":1602900530000},"page":"114291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Small cyclic sodium channel inhibitors"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0504-5702","authenticated-orcid":false,"given":"Steve","family":"Peigneur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"da Costa Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via Cristina","family":"de Sousa Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-0235","authenticated-orcid":false,"given":"Kirsten L.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-1310","authenticated-orcid":false,"given":"Alexander","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Cheneval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Cristina Nogueira Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-1744","authenticated-orcid":false,"given":"Hana","family":"Starobova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Dimitri Gama Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0007-6796","authenticated-orcid":false,"given":"David J.","family":"Craik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3594-9588","authenticated-orcid":false,"given":"Irina","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-6374","authenticated-orcid":false,"given":"Christina I.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bcp.2020.114291_b0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/14789450.2017.1377613","article-title":"Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery","volume":"14","author":"Robinson","year":"2017","journal-title":"Expert Rev. Proteomics"},{"issue":"12","key":"10.1016\/j.bcp.2020.114291_b0010","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1039\/C7MB00511C","article-title":"Pharmacology of predatory and defensive venom peptides in cone snails","volume":"13","author":"Prashanth","year":"2017","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.bcp.2020.114291_b0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.ctm.2016.07.001","article-title":"Venom peptides from cone snails: pharmacological probes for voltage-gated sodium channels","volume":"78","author":"Green","year":"2016","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.bcp.2020.114291_b0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.apha.2017.01.004","article-title":"Sodium channels and venom peptide pharmacology","volume":"79","author":"Israel","year":"2017","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114291_b0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/pr.111.005322","article-title":"Conus venom peptide pharmacology","volume":"64","author":"Lewis","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"15","key":"10.1016\/j.bcp.2020.114291_b0030","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.4155\/fmc.14.107","article-title":"Structure and function of mu-conotoxins, peptide-based sodium channel blockers with analgesic activity","volume":"6","author":"Green","year":"2014","journal-title":"Future Med. Chem."},{"issue":"28","key":"10.1016\/j.bcp.2020.114291_b0035","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1021\/bi000486w","article-title":"KcsA crystal structure as framework for a molecular model of the Na(+) channel pore","volume":"39","author":"Lipkind","year":"2000","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bcp.2020.114291_b0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1476-5381.2012.02004.x","article-title":"Mechanism and molecular basis for the sodium channel subtype specificity of micro-conopeptide CnIIIC","volume":"167","author":"Markgraf","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"19","key":"10.1016\/j.bcp.2020.114291_b0045","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1021\/bi0473408","article-title":"Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels","volume":"44","author":"Bulaj","year":"2005","journal-title":"Biochemistry"},{"issue":"25","key":"10.1016\/j.bcp.2020.114291_b0050","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1073\/pnas.1107027108","article-title":"mu-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve","volume":"108","author":"Wilson","year":"2011","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.bcp.2020.114291_b0055","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/mol.111.073460","article-title":"Interactions of key charged residues contributing to selective block of neuronal sodium channels by mu-conotoxin KIIIA","volume":"80","author":"McArthur","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"37","key":"10.1016\/j.bcp.2020.114291_b0060","doi-asserted-by":"crossref","first-page":"31382","DOI":"10.1074\/jbc.M112.375733","article-title":"Design of bioactive peptides from naturally occurring mu-conotoxin structures","volume":"287","author":"Stevens","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.bcp.2020.114291_b0065","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1111\/j.1742-4658.2011.08264.x","article-title":"Importance of position 8 in mu-conotoxin KIIIA for voltage-gated sodium channel selectivity","volume":"278","author":"Van Der Haegen","year":"2011","journal-title":"FEBS J."},{"issue":"42","key":"10.1016\/j.bcp.2020.114291_b0070","doi-asserted-by":"crossref","first-page":"30699","DOI":"10.1074\/jbc.M704616200","article-title":"Structure\/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels","volume":"282","author":"Zhang","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2020.114291_b0075","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/md8072153","article-title":"The tetrodotoxin receptor of voltage-gated sodium channels\u2013perspectives from interactions with micro-conotoxins","volume":"8","author":"French","year":"2010","journal-title":"Mar. Drugs"},{"issue":"6433","key":"10.1016\/j.bcp.2020.114291_b0080","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.aaw2999","article-title":"Molecular basis for pore blockade of human Na(+) channel Nav1.2 by the mu-conotoxin KIIIA","volume":"363","author":"Pan","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114291_b0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fphar.2011.00071","article-title":"Neurotoxins and their binding areas on voltage-gated sodium channels","volume":"2","author":"Stevens","year":"2011","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114291_b0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.toxicon.2018.07.008","article-title":"Phoneutria nigriventer venom: a pharmacological treasure","volume":"151","author":"Peigneur","year":"2018","journal-title":"Toxicon"},{"issue":"3\u20134","key":"10.1016\/j.bcp.2020.114291_b0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cbpc.2005.09.010","article-title":"Comparison of the partial proteomes of the venoms of Brazilian spiders of the genus Phoneutria","volume":"142","author":"Richardson","year":"2006","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114291_b0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-5793(90)81386-3","article-title":"The purification and amino acid sequence of the lethal neurotoxin Tx1 from the venom of the Brazilian 'armed' spider Phoneutria nigriventer","volume":"263","author":"Diniz","year":"1990","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.bcp.2020.114291_b0105","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.biochi.2012.08.016","article-title":"Inhibitory effect of the recombinant Phoneutria nigriventer Tx1 toxin on voltage-gated sodium channels","volume":"94","author":"Silva","year":"2012","journal-title":"Biochimie"},{"issue":"9\u201310","key":"10.1016\/j.bcp.2020.114291_b0110","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0300-9084(00)01174-3","article-title":"Molecular mechanisms of neurotoxin action on voltage-gated sodium channels","volume":"82","author":"Cestele","year":"2000","journal-title":"Biochimie"},{"issue":"6","key":"10.1016\/j.bcp.2020.114291_b0115","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1124\/mol.105.021147","article-title":"Phoneutria nigriventer toxin 1: a novel, state-dependent inhibitor of neuronal sodium channels that interacts with micro conotoxin binding sites","volume":"69","author":"Martin-Moutot","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114291_b0120","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1096\/fj.201801909R","article-title":"Where cone snails and spiders meet: design of small cyclic sodium-channel inhibitors","volume":"33","author":"Peigneur","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2020.114291_b0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2016.11.015","article-title":"NaV1.7 as a pain target - From gene to pharmacology","volume":"172","author":"Vetter","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2020.114291_b0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/toxins8030078","article-title":"Analgesic effects of GpTx-1, PF-04856264 and CNV1014802 in a mouse model of NaV1.7-mediated pain","volume":"8","author":"Deuis","year":"2016","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.bcp.2020.114291_b0135","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2020.114291_b0140","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1476-5381.1992.tb13413.x","article-title":"L-leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia","volume":"107","author":"Kawabata","year":"1992","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2020.114291_b0145","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.bcp.2020.114291_b0150","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114291_b0155","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1021\/acs.jmedchem.5b01947","article-title":"Single residue substitutions that confer voltage-gated sodium ion channel subtype selectivity in the NaV1.7 inhibitory peptide GpTx-1","volume":"59","author":"Murray","year":"2016","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2020.114291_b0160","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/cb400012k","article-title":"Chemical engineering and structural and pharmacological characterization of the alpha-scorpion toxin OD1","volume":"8","author":"Durek","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2020.114291_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(00)29002-X","article-title":"Sodium channels and the molecular pathophysiology of pain","volume":"129","author":"Cummins","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.bcp.2020.114291_b0170","series-title":"Sodium Channel Blocker Toxicity","author":"Dokken","year":"2020"},{"key":"10.1016\/j.bcp.2020.114291_b0175","series-title":"Lidocaine","author":"Beecham","year":"2020"},{"issue":"3","key":"10.1016\/j.bcp.2020.114291_b0180","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bja.2019.06.014","article-title":"Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review","volume":"123","author":"Hermanns","year":"2019","journal-title":"Br. J. Anaesth."},{"issue":"12","key":"10.1016\/j.bcp.2020.114291_b0185","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/bph.13962","article-title":"Sodium channels and pain: from toxins to therapies","volume":"175","author":"Cardoso","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114291_b0190","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1523\/JNEUROSCI.19-06-02181.1999","article-title":"Role of protein kinase A in the maintenance of inflammatory pain","volume":"19","author":"Aley","year":"1999","journal-title":"J. Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2020.114291_b0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1469-7793.1999.0433v.x","article-title":"cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS","volume":"516","author":"Fitzgerald","year":"1999","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114291_b0200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2003.12.035","article-title":"Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain","volume":"108","author":"Black","year":"2004","journal-title":"Pain"},{"issue":"24","key":"10.1016\/j.bcp.2020.114291_b0205","doi-asserted-by":"crossref","first-page":"10345","DOI":"10.1523\/JNEUROSCI.18-24-10345.1998","article-title":"Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro","volume":"18","author":"Gold","year":"1998","journal-title":"J. Neurosci."},{"issue":"52","key":"10.1016\/j.bcp.2020.114291_b0210","doi-asserted-by":"crossref","first-page":"14062","DOI":"10.1523\/JNEUROSCI.3795-08.2008","article-title":"Nociceptors are interleukin-1beta sensors","volume":"28","author":"Binshtok","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2020.114291_b0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresrev.2008.12.005","article-title":"Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment","volume":"60","author":"Dib-Hajj","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2020.114291_b0220","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0026-895X(24)12544-8","article-title":"Endothelin B receptor modulates inflammatory pain and cutaneous inflammation","volume":"56","author":"Griswold","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114291_b0225","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0854.2009.01027.x","article-title":"Prostaglandin E2 promotes Na1.8 trafficking via its intracellular RRR motif through the protein kinase A pathway","volume":"11","author":"Liu","year":"2010","journal-title":"Traffic"},{"issue":"1","key":"10.1016\/j.bcp.2020.114291_b0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(98)00738-1","article-title":"A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat","volume":"256","author":"Khasar","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"7608","key":"10.1016\/j.bcp.2020.114291_b0235","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nature17976","article-title":"Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain","volume":"534","author":"Osteen","year":"2016","journal-title":"Nature"},{"issue":"51","key":"10.1016\/j.bcp.2020.114291_b0240","doi-asserted-by":"crossref","first-page":"35341","DOI":"10.1074\/jbc.M114.610436","article-title":"delta-Conotoxins synthesized using an acid-cleavable solubility tag approach reveal key structural determinants for NaV subtype selectivity","volume":"289","author":"Peigneur","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2020.114291_b0245","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/md12042132","article-title":"Action of clathrodin and analogues on voltage-gated sodium channels","volume":"12","author":"Peigneur","year":"2014","journal-title":"Mar. Drugs"},{"issue":"10","key":"10.1016\/j.bcp.2020.114291_b0250","doi-asserted-by":"crossref","DOI":"10.3390\/md16100352","article-title":"Addressing the issue of tetrodotoxin targeting","volume":"16","author":"Melnikova","year":"2018","journal-title":"Mar. Drugs"},{"issue":"2","key":"10.1016\/j.bcp.2020.114291_b0255","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/md10020281","article-title":"Tetrodotoxin (TTX) as a therapeutic agent for pain","volume":"10","author":"Nieto","year":"2012","journal-title":"Mar. Drugs"},{"issue":"7625","key":"10.1016\/j.bcp.2020.114291_b0260","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature19791","article-title":"Accurate de novo design of hyperstable constrained peptides","volume":"538","author":"Bhardwaj","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2020.114291_b0265","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The future of peptide-based drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"issue":"9","key":"10.1016\/j.bcp.2020.114291_b0270","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1021\/jm400041h","article-title":"Determination of the alpha-conotoxin Vc1.1 binding site on the alpha9alpha10 nicotinic acetylcholine receptor","volume":"56","author":"Yu","year":"2013","journal-title":"J. Med. Chem."},{"issue":"Oct 2","key":"10.1016\/j.bcp.2020.114291_bib271","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.3390\/biomedicines8100391","article-title":"Discovery, Pharmacological Characterisation and NMR Structure of the Novel \u00b5-Conotoxin SxIIIC, a Potent and Irreversible NaV Channel Inhibitor","volume":"8","author":"McMahon","year":"2020","journal-title":"Biomedicines"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522030527X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522030527X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:16:21Z","timestamp":1777400181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522030527X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":55,"alternative-id":["S000629522030527X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114291","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small cyclic sodium channel inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114291"}}